Chromadex Corp
Change company Symbol lookup
Select an option...
CDXC Chromadex Corp
NIB iPath� Bloomberg Cocoa Subindex Total Return(SM) ETN
DG Dollar General Corp
SPCO Stephan Co
KEX Kirby Corp
GM General Motors Co
F Ford Motor Co
MSFT Microsoft Corp
TWTR Twitter Inc
CCL Carnival Corp
Go

Health Care : Life Sciences Tools & Services | Small Cap Blend
Company profile

ChromaDex Corp. is a global bioscience company, which is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. NAD+ is a coenzyme and a regulator of cellular metabolism. It operates through three segments: Consumer products, Ingredients, and Analytical reference standards and services segment. The Consumer products segment provides finished dietary supplement products that contain the ingredients directly to consumers as well as to distributors. The Ingredients segment develops and commercializes ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The Analytical reference standards and services segment supplies phytochemical reference standards and other research and development services. Its ingredients include Tru Niagen and Immulina. The Tru Niagen is a form nicotinamide riboside (NR). NR is a member of the vitamin B3 family. Immulina is a spirulina extract.

Closing Price
$1.69
Day's Change
0.03 (1.81%)
Bid
--
Ask
--
B/A Size
--
Day's High
1.76
Day's Low
1.67
Volume
(Heavy Day)
Volume:
499,182

10-day average volume:
347,750
499,182
  • Prev Close
    1.66
  • Today's Open
    1.73
  • Day's Range
    1.67-1.76
  • Avg Vol (10-day)
    347.8K
  • Last (time)
    4:00p ET 08/12/22
  • Last (size)
    300
  • 52-Wk Range
    1.51 - 8.79
    LowHigh
  • (08/12/21 - 05/13/22)
    11.92%
  • 78.1%
  • Market Cap
    115.5M
  • Shares Outstanding
    68.3M
  • -0.40
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.7
  • 27.85
  • (% of float 07/29/22)
    5.34

Latest News

August 10, 2022
4:02 pm ET
BusinessWire
August 02, 2022
6:32 am ET
BusinessWire
July 07, 2022
6:32 am ET
BusinessWire
June 15, 2022
6:34 am ET
BusinessWire
June 10, 2022
9:31 am ET
PR Newswire
6:32 am ET
BusinessWire
June 07, 2022
1:33 pm ET
BusinessWire
June 02, 2022
6:34 am ET
BusinessWire
June 01, 2022
6:32 am ET
BusinessWire
May 19, 2022
4:34 pm ET
BusinessWire
May 17, 2022
6:34 am ET
BusinessWire
March 10, 2022
8:15 am ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.